Summer 2025 Prime Therapeutics Report: Spotlight on HIV and Specialty Drug Trends - Prime Therapeutics
Summer 2025 Prime Therapeutics Report: Spotlight on HIV and Specialty Drug Trends
New therapies, payer strategies and pipeline updates shaping the future of managed care
The Prime Therapeutics Report is your trusted source for the latest in managed care strategies, specialty drug trends and payer-focused insights. The Summer 2025 issue features a cover story on HIV treatment, including updates on pre-exposure prophylaxis, post-exposure prophylaxis and therapies in the pipeline. The report also highlights developments in:
Duchenne Muscular Dystrophy (DMD):
Focus on new gene therapies
Considerations for payers and reimbursement
Biosimilar Market:
Latest updates and trends
Ophthalmology:
Insights into anti-VEGF agents used in eye treatments
Cardiology:
Advances in managing transthyretin amyloid cardiomyopathy
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.